World Market for Prescription Generic Drugs, 6th Edition

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

• Introduction
• Scope and Methodology
• Size and Growth of the Market
• Trends Affecting the Market
• Market Outlook

CHAPTER TWO:INTRODUCTION

• Industry Development
• Generic Drug Industry Evolution
• FDA Regulation
  • Development and Approval Process
• Industry Structure
• Product Distribution
• Patent Expirations

CHAPTER THREE: ALLERGY AND RESPIRATORY DRUGS

• Product Categories
  • Asthma, Bronchodilators and Corticosteroids
  • Inhaled Corticosteroids
  • Antiasthmatic Agents
  • Bronchodilating Agents
  • Antihistamines, Decongestants, and Cough Preparations
  • Antihistamines
  • Decongestants
  • Cough Preparations
• Product News
• Market Size and Forecast
  • The World Market
  • The U.S. vs World Market
• Competitive Analysis

CHAPTER FOUR: ANALGESICS, NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, AND ANTIRHEUMATIC DRUGS

• Product Categories
  • Analgesics
  • Nonsteroidal Anti-inflammatory Drugs
  • Antirheumatics
• Product News
• Market Size and Forecast
• The World Market
• The U.S. vs World Market
• Competitive Analysis

CHAPTER FIVE: ANESTHESIA DRUGS

• Product Categories
• General
• Local
• Regional
• Product News
• Market Size and Forecast
• The World Market
• The U.S. vs World Market

CHAPTER SIX: ANTI-INFECTIVES

• Product Categories
• Systemic Anti-Infectives
• Topical Anti-Infectives
• Product News
• Market Size and Forecast
• The World Market
• The U.S. vs World Market Competitive Analysis

CHAPTER SEVEN: CANCER DRUGS

• Products
• Product News
• Market Size and Forecast
• The World Marke
• The U.S. vs World Market
• Competitive Analysis

CHAPTER EIGHT: CARDIOVASCULAR DRUGS

• Product Categories
  • Positive Inotropic Agents
  • Antiadrenergics
  • Beta-Adrenergic Blocking Agents
  • Vasodilators
  • Calcium Channel Blockers
  • Angiotensin-Converting Enzyme Inhibitors
  • Antiarrhythmics
  • Antihyperlipidemic Agents
  • Anticoagulants
  • Diuretics
• Product News
• Market Size and Forecast
• The World Market
• The U.S. vs. World Market
• Competitive Analysis

CHAPTER NINE: CENTRAL NERVOUS SYSTEM AND PSYCHOTHERAPEUTIC DRUGS

• Product Categories
  • Antidepressants, Stimulants, and Antipsychotics
  • Antidepressants
  • Stimulants
  • Antipsychotics
  • Anticonvulsants, Antispasmodics, and Muscle Relaxants
  • Anticonvulsants
  • Antispasmodics
  • Muscle Relaxants
  • Parkinson' s Disease, Myasthenia Gravis, and Multiple Sclerosis
  • Parkinson' s Disease
  • Myasthenia Gravis
  • Multiple Sclerosis
  • Sedatives, Hypnotics, and Antianxiety Drugs
• Product News
• Market Size and Forecast
• The World Market
• The U.S. vs World Market
• Competitive Analysis

CHAPTER TEN: GASTROINTESTINAL DRUGS

• Product Categories
• Antidiarrheals
• Antinauseants
• Antispasmodics
• Antiulcer
• Digestants
• Product News
• Market Size and Forecast
• The World Market
• The U.S. vs the World Market
• Competitive Analysis

CHAPTER ELEVEN: HORMONAL DRUGS

• Product Categories
• Male and Female Hormones
• Bone Metabolism Regulators
• Corticosteroids
• Diabetes Drugs
• Thyroid Drugs
• Product News
• Market Size and Forecast
• The World Market
• U.S. vs World Market
• Competitive Analysis

CHAPTER TWELVE: OPHTHALMIC DRUGS

• Product Categories
  • Ophthalmic Anti-Infectives
  • Ophthalmic Anti-Inflammatories and Mast Cell Inhibitors
  • Glaucoma Agents
• Product News
• Market Size and Forecast
• The World Market
• U.S. vs World Market
• Competitive Analysis

CHAPTER THIRTEEN: WORLD MARKET SUMMARY

• Overview
• Total Market Size and Forecast
• Market and Competitive Analysis

CHAPTER FOURTEEN: ISSUES AND TRENDS

• Understanding Hatch-Waxman and Its Shortfalls
• The FDA, Funding and Review Times
• Big Pharma Tactics-Defensive and Offensive
• Authorized Generics
• Generic Biologics
• Medicaid Generic Drug Reimbursement Issues
• The Elderly
• Confusion in Generic Drug Names
• Broadening Generic Horizons
• International Generic Drug Issues
• Indian Drug Makers
• Industry Consolidation
• New Generic Giants
• Patent Issues: Filings and Challenges
• Generic Companies Increasingly Aggressive
• Patent Reform
• Generic Growth: Prescriptions, Approvals, Impact
• Generic Statins Countdown
• Prescription Drug Costs
• Generics Improve Compliance
• Generic Drug Sampling

CHAPTER FIFTEEN: COMPANY PROFILES

• Industry Structure and Participants
• Actavis Group
• APOTEX, Inc.
• Aurobindo Pharma, Ltd
• Barr Laboratories, Inc.
• Bedford Laboratories
• Dr Reddy' s Laboratories Limited
• Dragon Pharmaceuticals, Inc.
• Hospira Inc.
• Mylan Laboratories, Inc.
• Orchid Chemicals and Pharmaceuticals, Ltd.
• Par Pharmaceuticals, Inc.
• Perrigo Company
• PLIVA Pharmaceuticals, Inc.
• Ranbaxy Laboratories, Ltd.
• Roxane Laboratories, Inc.
• Sandoz
• Taro Pharmaceutical Industries Ltd.
• TEVA Pharmaceutical Industries, Ltd.
• Watson Pharmaceuticals, Inc.
• United Research Laboratories and Mutual Pharmaceutical Company
• Zydus Pharmaceuticals, Inc.
• APPENDIX: COMPANY DIRECTORY

LIST OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

• Figure 1-1: The World Market for Prescription Generic Drugs Revenues by Segment 2002-201

CHAPTER TWO: INTRODUCTION

• Figure 2-1: Abbreviated New Drug Application Review Flow Chart
• Table 2-1: Brand Name Companies with Generic Subsidiaries
• Table 2-2: Number of Best Selling Drugs with Patents Expiring in Years 2006-2012 Grouped by Treatment Category
• Table 2-3: Best Selling Prescription Drugs with Expected Patent Expiration (Year of Expiration, Brand, Manufacturer, Indication, 2007 Revenues) 2006-2012

CHAPTER THREE:ALLERGY AND RESPIRATORY DRUGS

• Table 3-1: Prescription Allergy and Respiratory ANDA Approvals, 2006-2007
• Table 3-2: The World Market for Prescription Generic Allergy and Respiratory Drugs by Type 2002-2012
• Figure 3-1: The World Market for Prescription Generic Allergy and Respiratory Drugs, Revenues by Type 2002-2012
• Table 3-3: The World Market for Prescription Generic Allergy and Respiratory Drugs, Market Share by Type 2002-2012
• Table 3-4: The World Market for Prescription Generic Allergy and Respiratory Drugs, U.S. Revenues and Share 2002-2012
• Figure 3-2: The World Market for Prescription Generic Allergy and Respiratory Drugs, Displaying U.S. Revenues 2002-2012
• Table 3.5: The World Market for Prescription Generic Allergy and Respiratory Drugs, Revenues and Market Share by Supplier 2007
• Figure 3-3: The World Market for Prescription Generic Allergy and Respiratory Drugs, Market Share by Leading Supplier 2005

CHAPTER FOUR: ANALGESICS, NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, AND ANTIRHEUMATIC DRUGS

• Table 4-1: Prescription Generic Analgesic, NSAID, and Antirheumatic ANDA Approvals, 2005
• Table 4-2: The World Market for Prescription Generic Analgesics, NSAIDs and Antirheumatic Drugs by Type 2002-2012
• Figure 4-1: The World Market for Prescription Generic Analgesics, NSAIDs, and Antirheumatic Drugs, Revenues by Type 2002-2012
• Table 4-3: The World Market for Prescription Generic Analgesics, NSAIDs, and Antirheumatic Drugs, Market Share by Type 2002-2012
• Table 4-4: The World Market for Prescription Generic Analgesics, NSAIDs, and Antirheumatic Drugs, U.S. Revenues and Share 2002-2012
• Figure 4-2: The World Market for Prescription Generic Analgesics, NSAIDs, and Antirheumatic Drugs Displaying U.S. Revenues 2002-2012
• Table 4-5: The World Market for Prescription Generic Analgesics, NSAIDs, and Antirheumatic Drugs Revenues and Market Share by Supplier 2007
• Figure 4-3: The World Market for Prescription Generic Analgesics, NSAIDs, and Antirheumatic Drugs Market Share by Leading Supplier 2007

CHAPTER FIVE: ANESTHESIA DRUGS

• Table 5-1: Prescription Generic Anesthesia Drug ANDA Approvals, 2006
• Table 5-2: The World Market for Prescription Generic Anesthesia Drugs 2002-2012
• Figure 5-1: The World Market for Prescription Generic Anesthesia Drugs Revenues 2002-2012
• Table 5-3: The World Market for Prescription Generic Anesthesia Drugs, U.S. Revenues and Share 2002-2012
• Figure 5-2: The World Market for Prescription Generic Anesthesia Drugs Displaying U.S. Revenues 2002-2012
• Table 5-4: The World Market for Prescription Generic Anesthesia Drugs, Revenues and Market Share by Supplier 2007
• Figure 5-3: The World Market for Prescription Generic Anesthesia Drugs Market Share by Leading Supplier 2007

CHAPTER SIX: ANTI-INFECTIVES

• Table 6-1: Prescription Generic Anti-infective Drug ANDA Approvals, 2005
• Table 6-2: The World Market for Prescription Generic Anti-Infective Drugs by Type 2002-2012
• Figure 6-1: The World Market for Prescription Generic Anti-Infective Drugs, Revenues by Type 2002-2012
• Table 6-3: The World Market for Prescription Generic Anti-Infective Drugs, Market Share by Type 2002-2012
• Table 6-4: The World Market for Prescription Generic Anti-Infective Drugs U.S. Revenues and Share 2002-2012
• Figure 6-2: The World Market for Prescription Generic Anti-Infective Drugs Displaying U.S. Revenues 2002-2012
• Table 6-5: The World Market for Prescription Generic Anti-Infective Drugs, Revenues and Market Share by Supplier 2007
• Figure 6-3: The World Market for Prescription Generic Anti-Infective Drugs Market Share by Leading Supplier 2007

CHAPTER SEVEN: CANCER DRUGS

• Table 7-1: Prescription Generic Cancer Drug ANDA Approvals 2006-2007
• Table 7-2: The World Market for Prescription Generic Cancer Drugs 2002-2012
• Figure 7-1: The World Market for Prescription Generic Cancer Drugs Revenues 2002-2012
• Table 7-3: The World Market for Prescription Generic Cancer Drugs, U.S. Revenues and Share 2002-2012
• Figure 7-2: The World Market for Prescription Generic Cancer Drugs Displaying U.S. Revenues 2002-2012
• Table 7-4: The World Market for Prescription Generic Cancer Drugs, Revenues and Market Share by Supplier 2007
• Figure 7-3: The World Market for Prescription Generic Cancer Drugs Market Share by Leading Supplier 2007

CHAPTER EIGHT: CARDIOVASCULAR DRUGS

• Table 8-1: Prescription Generic Cardiovascular Drug ANDA Approvals. 2006-2007
• Table 8-2: The World Market for Prescription Generic Cardiovascular Drugs by Type 2002-2012
• Figure 8-1: The World Market for Prescription Generic Cardiovascular Drugs Revenues by Type 2002-2012
• Table 8-3: The World Market for Prescription Generic Cardiovascular Drugs, Market Share by Type 2002-2012
• Figure 8-2: The World Market for Prescription Generic Cardiovascular Drugs, Share by Type 2007 and 2012
• Table 8-4: The World Market for Prescription Generic Cardiovascular Drugs U.S. Revenues and Share 2002-2012
• Figure 8-3: The World Market for Prescription Generic Cardiovascular Drugs Displaying U.S. Revenues 2002-2012
• Table 8-5: The World Market for Prescription Generic Cardiovascular Drugs, Revenues and Market Share by Supplier 2007
• Figure 8-4: The World Market for Prescription Generic Cardiovascular Drugs, Market Share by Leading Supplier 2007

CHAPTER NINE: CENTRAL NERVOUS SYSTEM AND PSYCHOTHERAPEUTIC DRUGS

• Table 9-1: Prescription Generic Central Nervous System/Psychotherapeutic Drug ANDA Approvals 2006-2007 Table 9-2: The World Market for Prescription Generic Central Nervous System Drugs by Type 2002-2012
• Figure 9-1: The World Market for Prescription Generic Central Nervous System Drugs Revenues by Type 2002-2012
• Table 9-3: The World Market for Prescription Generic Central Nervous System Drugs, Market Share by Type 2002-2012
• Table 9-4: The World Market for Prescription Generic Central Nervous System Drugs, U.S. Revenues and Share 2002-2012
• Figure 9-2 : The World Market for Prescription Generic Central Nervous System Drugs Displaying U.S. Revenues 2002-2012
• Table 9-5 : The World Market for Prescription Generic Central Nervous System Drugs, Revenues and Market Share by Supplier 2007
• Figure 9-3 : The World Market for Prescription Generic Central Nervous System Drugs, Market Share by Leading Supplier 2007

CHAPTER TEN: GASTROINTESTINAL DRUGS

• Table 10-1: Prescription Generic Gastrointestinal Drug ANDA Approvals 2006-2007
• Table 10-2: The World Market for Prescription Generic Gastrointestinal Drugs by Type, 2002-2012
• Figure 10-1: The World Market for Prescription Generic Gastrointestinal Drugs Revenues by Type 2002-2012
• Table 10-3: The World Market for Prescription Generic Gastrointestinal Drugs, Market Share by Type 2002-2012
• Figure 10-2: The World Market for Prescription Generic Gastrointestinal Drugs, Share by Type 2007 and 2012
• Table 10-4: The World Market for Prescription Generic Gastrointestinal Drugs, U.S. Revenues and Share 2002-2012
• Figure 10-3: The World Market for Prescription Generic Gastrointestinal Drugs, Displaying U.S. Revenues 2002-2012
• Table 10-5: The World Market for Prescription Generic Gastrointestinal Drugs, Revenues and Market Share by Supplier 2007
• Figure 10-4: The World Market for Prescription Generic Gastrointestinal Drugs, Market Share by Leading Supplier 2007

CHAPTER ELEVEN: HORMONAL DRUGS

• Table 11-1: Prescription Generic Hormone Drug ANDA Approvals 2006-2007
• Table 11-2: The World Market for Prescription Generic Hormone Drugs by Type 2002-2012
• Figure 11-1: The World Market for Prescription Generic Hormone Drugs Revenues by Type 2002-2012
• Table 11-3: The World Market for Prescription Generic Hormone Drugs, Market Share by Type 2002-2012
• Figure 11-2: The World Market for Prescription Generic Hormone Drugs Share by Type 2007 and 2012
• Table 11-4: The World Market for Prescription Generic Hormone Drugs U.S. Revenues and Share 2002-2012
• Figure 11-3: The World Market for Prescription Generic Hormone Drugs Displaying U.S. Revenues 2002-2012
• Table 11-5: The World Market for Prescription Generic Hormone Drugs, Revenues and Market Share by Supplier 2007
• Figure 11-4: The World Market for Prescription Generic Hormone Drugs Market Share by Leading Supplier 2007

CHAPTER TWELVE: OPHTHALMIC DRUGS

• Table 12-1: Prescription Generic Ophthalmic Drug ANDA Approvals 2006-2007
• Table 12-2: The World Market for Prescription Generic Ophthalmic Drugs by Type 2002-2012
• Figure 12-1: The World Market for Prescription Generic Ophthalmic Drugs Revenues by Type 2002-2012
• Table 12-3: The World Market for Prescription Generic Ophthalmic Drugs, Market Share by Type 2002-2012
• Table 12-4: The World Market for Prescription Generic Ophthalmic Drugs, U.S. Revenues and Share 2002-2012
• Figure 12-2: The World Market for Prescription Generic Ophthalmic Drugs Displaying U.S. Revenues 2002-2012
• Table 12-5: The World Market for Prescription Generic Ophthalmic Drugs, Revenues and Market Share by Supplier 2007
• Figure 12-3: The World Market for Prescription Generic Ophthalmic Drugs Market Share by Leading Supplier 2007

CHAPTER THIRTEEN: WORLD MARKET SUMMARY

• Table 13-1: The World Market for Prescription Generic Drugs Revenues by Segment 2002-2012
• Figure 13-1: The World Market for Prescription Generic Drugs Revenues by Segment 2002-2012
• Figure 13-2: The World Market for Generic Drugs Market Share by Type 2007 and 2012
• Table 13-2: World Market for Prescription Generic Drugs Revenues and Segments of Participation by Leading Player 2007